Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation — Hao Song (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation
Shared by
De Clercq Erik
KU Leuven
5-Cyano substituted diarylpyridines as potent HIV-1 NNRTIs: Rational design, synthesis, and activity evaluation
Article
2023
en
Authors
+7 more
HS
Hao Song
YX
Yu Xia
TZ
Tao Zhang
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Design, synthesis and anti-HIV evaluation of novel 5-substituted diarylpyrimidine derivatives as potent HIV-1 NNRTIs
Ping Gao
,
Shu Song
,
Zhao Wang
,
Lin Sun
,
Jian Zhang
,
Christophe Pannecouque
,
De Clercq Erik
,
Peng Zhan
,
Xinyong Liu
Article
2021
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies
Dongwei Kang
,
Francesc X. Ruiz
,
Yanying Sun
,
Da Feng
,
Lanlan Jing
,
Zhao Wang
,
Tao Zhang
,
Shenghua Gao
,
Lin Sun
,
De Clercq Erik
,
Christophe Pannecouque
,
Eddy Arnold
,
Peng Zhan
,
Xinyong Liu
Article
2018
Design, synthesis and biological evaluation of novel acetamide-substituted doravirine and its prodrugs as potent HIV-1 NNRTIs
Zhao Wang
,
Yu Zhao
,
Dongwei Kang
,
Jian Zhang
,
Ye Tian
,
Dirk Daelemans
,
De Clercq Erik
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
Article
2009
Design, Synthesis and Anti-HIV-1 Evaluation of Novel Arylazolylthioacetanilides as Potent NNRTIS
Xinyong Liu
,
Peng Zhan
,
Christophe Pannecouque
,
De Clercq Erik
Article
2017
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs
Zhaoqiang Liu
,
Ye Tian
,
Jinghan Liu
,
Boshi Huang
,
Dongwei Kang
,
De Clercq Erik
,
Dirk Daelemans
,
Christophe Pannecouque
,
Peng Zhan
,
Xinyong Liu
Discussion(0)
No comments yet. Be the first to comment.